Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Open in API
Filings indexed 3,304 across all filing types
Latest filing 2020-12-14 Regulatory Filings
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
425 Filing
Regulatory Filings
2020-12-14 English
BLOCK LISTING INTERIM REVIEW
Foreign Filer Report
2020-12-01 English
TOTAL VOTING RIGHTS
Foreign Filer Report
2020-12-01 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is a regulatory notification from AstraZeneca PLC regarding its total voting rights and issued share capital, filed in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. This type of disclosure is a standard regulatory requirement for companies to inform shareholders of the denominator for calculating interest notifications. Since it does not fit into specific categories like 'Major Shareholding Notification' (which is for individual investors) or 'Share Issue' (which is for specific capital changes), it falls under the general regulatory filing category.
2020-12-01 English
Block listing Interim Review
Share Issue/Capital Change Classification · 99% confidence The document is explicitly titled 'BLOCK LISTING SIX MONTHLY RETURN' and is distributed via 'RNS Number'. It details the balance and movement of unallotted securities under various share option plans over a specific period (1 June 2020 to 30 November 2020). This type of filing, which reports on the status of securities reserved for employee share schemes, is a routine regulatory disclosure. Since it is a specific regulatory filing that doesn't fit the definitions for 10-K, AR, ER, or IR, and it is not an announcement of a report (RPA), the most appropriate general category for routine regulatory disclosures not covered elsewhere is 'Regulatory Filings' (RNS).
2020-12-01 English
CRESTOR TO BE DIVESTED TO GRUNENTHAL IN EUROPE
Foreign Filer Report
2020-12-01 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.